We are doing it now, but we have treated fewer than 10 patients with benign essential tremor. What we have identified is what we call a preclinical model for breaking down the blood-brain barrier, which means that we're not yet doing this in humans. We have the opportunity, by investing in infrastructure, to bring those individuals together in the same environment and get the synergy that we believe will actually help to change the future of disorders like dementia and depression for those patients across the entire country.
The infrastructure, the environment of bringing everyone together in one centre, is different from what exists in Vancouver. In Vancouver, it's more around research. This is research embedded in care, and we believe this is the model that's going to result in the best return on investment.